05212022Sat
Last updateWed, 09 Mar 2022 4am

The fallopian tube is the culprit and an accomplice in type II ovarian cancer: A review

Mun-Kun Honga, b, Tang-Yuan Chua, b, Dah-Ching Dinga, b

a Department of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
b Institute of Medical Science, Tzu Chi University, Hualien, Taiwan

Full-Text HTML Download PDF


Abstract
Ovarian cancer is the most lethal gynecologic malignancy in the world. The origin or the pathogenesis of epithelial ovarian cancer is poorly understood, which often leads to failure of early detection. Development of a new approach to reduce mortality is urgent. The fallopian tubes were once seen as an extremely rare site for cancer, but increasing evidence now suggests that they could be involved in initiation of the most aggressive ovarian carcinoma. As a result of evolution to prevent ectopic pregnancy, not only is the fallopian tube “poor soil” for carcinogenesis, but angiogenesis is also inhibited there. However, every cycle of ovulation results in changes in which tubal epithelial cells are dislodged and implanted on the denuded surface of the ovary, resulting in the formation of an inclusion cyst. This is the very beginning of serous ovarian carcinogenesis. To prevent ovarian cancer, a salpingectomy might be recommended during hysterectomy because this procedure can effectively reduce the incidence of ovarian cancer. Application of these new concepts will allow for a more rational approach to screening, treatment, and prevention, which could potentially have a significant impact in reducing mortality from this devastating disease.

Keywords
Fallopian tube; Ovarian carcinogenesis; Salpingectomy


 

On the Cover

Search all Issue